ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“Present your findings to an international audience of academics, scientists, and leaders from the pharmaceutical industry, at one of the most important events in cancer drug discovery.
New this year: Trial in Progress (TiP) abstracts in all phases of clinical research may be submitted.
Deadline: 16 December 2025 Submit your abstract.
More Posts Featuring ESMO.